Using gemcitabine hydrochloride as an internal standard, an accurate, sensitive, precise and robust reverse phase high performance liquid chromatographic (RP-HPLC) method has been developed for the estimation of bendamustine in bulk and dosage forms. The proposed method was validated as per the ICH guidelines (2005) and can be applied for the quantitative analysis of bendamustine in bulk and pharmaceutical dosage forms. The chromatographic separation was performed on ODS C-18 RP column (4.6 mm i.d x 250 mm) at ambient temperature using a mixture of methanol : water (50:50 v/v) as a mobile phase and at a flow rate of 1.0 ml/ min, while UV detection was performed at 232 nm. The retention times of gemcitabine and bendamustine were in the ranges of 6.647–6.797 and 11.66–12.49 minutes, respectively. The method was found to be linear in the range of 1 – 10 μg/ml. The LOD and LOQ for bendamustine were found to be 0.0422 and 0.1279 µg/ml respectively. Analytical recovery varied from 98.9% to 99.13%. The percentage RSD for precision and accuracy of the method was found to be less than 2%.
Comments: 8 Pages. OK
[v1] 2019-05-19 05:26:34
Unique-IP document downloads: 1 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.